BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37518005)

  • 1. Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial.
    Goto Y; Niizeki T; Fukutomi S; Shirono T; Shimose S; Iwamoto H; Kojima S; Kanno H; Uchino Y; Sasaki S; Shirahama N; Muroya D; Nomura Y; Akashi M; Nakayama G; Hirakawa Y; Sato T; Yoshitomi M; Sakai H; Hisaka T; Kakuma T; Koga H; Torimura T; Akagi Y; Okuda K
    Kurume Med J; 2023 Sep; 68(3.4):239-245. PubMed ID: 37518005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy].
    Li BK; Cui BK; Yuan YF; Li JQ; Zhang YQ; Shi M; Li GH
    Ai Zheng; 2005 Jul; 24(7):769-73. PubMed ID: 16004798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.
    Zhong C; Guo RP; Li JQ; Shi M; Wei W; Chen MS; Zhang YQ
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1437-45. PubMed ID: 19408012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors.
    Arita J; Ichida A; Nagata R; Mihara Y; Kawaguchi Y; Ishizawa T; Akamatsu N; Kaneko J; Hasegawa K
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):732-740. PubMed ID: 35306748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimally Invasive Conversion Hepatectomy for Advanced Hepatocellular Carcinoma].
    Sakai H; Goto Y; Shimose S; Niizeki T; Kawaguchi T; Akiba J; Yano H; Akagi Y; Fujita F; Hisaka T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1572-1574. PubMed ID: 38303345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proper hepatic pedicle clamping during hepatectomy is associated with improved postoperative long-term prognosis in patients with AJCC stage IIIB hepatocellular carcinoma.
    Li X; Liu S; Li H; Guo L; Zhang B; Lin Z; Zhang J; Ye Q
    Oncotarget; 2016 Apr; 7(17):24623-32. PubMed ID: 27027437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
    Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L
    Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma.
    Poon RT; Fan ST; Yu WC; Lam BK; Chan FY; Wong J
    Arch Surg; 2001 Jun; 136(6):693-9. PubMed ID: 11387012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
    Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
    Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?
    Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
    World J Surg; 2007 Dec; 31(12):2370-7. PubMed ID: 17912587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection.
    Paik KY; Kim EK
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):158-64. PubMed ID: 27020632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.
    Zhang YF; Guo RP; Zou RH; Shen JX; Wei W; Li SH; OuYang HY; Zhu HB; Xu L; Lao XM; Shi M
    Eur Radiol; 2016 Jul; 26(7):2078-88. PubMed ID: 26396105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.